InvestorsHub Logo
Followers 22
Posts 974
Boards Moderated 0
Alias Born 03/24/2011

Re: None

Thursday, 12/15/2011 2:55:04 AM

Thursday, December 15, 2011 2:55:04 AM

Post# of 110
Remedent is hitting an inflection point which will soon be noticed by the market. Growing Chinese revenues, higher amounts of venneer sales in the Middle East and cost cutting will soon lead to positive EPS at a ridiculously low valuation.

I have spoken with management many times. This company is the real deal.